GRCE Insider Trading Activity and SEC Form 4 Filings
GRCE insider trading summary
Over the past 12 months, insiders at Grace Therapeutics, Inc. (GRCE) reported 21 open-market purchases worth $593K by 1 insider and no sales on SEC Form 4. Net insider buying was $593K.
Latest GRCE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $5K (3,087 @ $1.77) |
| Nov 4, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $9K (5,027 @ $1.80) |
| Nov 3, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $18K (10,328 @ $1.79) |
| Oct 26, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $117K (66,411 @ $1.77) |
| Oct 22, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $41K (21,390 @ $1.93) |
| Oct 19, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $8K (4,256 @ $1.88) |
| Oct 16, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $69K (36,347 @ $1.89) |
| Oct 15, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $46K (23,485 @ $1.95) |
| Oct 14, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $22K (11,233 @ $1.93) |
| Oct 12, 2026 | Opaleye Management Inc. | 10% Owner | Buy | $15K (7,215 @ $2.02) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.